Posts for Ticker ‘NUVA’

Top Analyst Upgrades (AGN, CHU, ENDP, FLR, GD, LMT, MDZ, NETL, NUVA, SGR)

These are the top pre-market analyst upgrades and positive research calls we have seen from Wall Street this Tuesday morning:

Allergan (AGN) Raised to Overweight at Thomas Weisel.
China Unicom (CHU) Raised to Buy at UBS.
Endo Pharmaceuticals (ENDP) Started as Overweight at Thomas Weisel.
Fluor (FLR) Started as Outperform at Baird.
General Dynamics (GD) Started as Outperform at Morgan Keegan.
Lockheed Martin (LMT) Started as Outperform at Morgan Keegan.
MDS Inc. (MDZ) Raised to Buy at Jefferies.
NetLogic (NETL) Raised to Buy at Piper Jaffray.
Nuvasive (NUVA) Raised to Buy at Needham.
Shaw Group (SGR) Started as Outperform at Baird.

JON C. OGG

Top Pre-Market Analyst Upgrades (AMAG, ANDE, BAC, BMC, CDNS, CTXS, IPAR, JEF, MDR, MYGN, NUVA, SYMC)

These are some of the top pre-market analyst upgrades we are seeing this Wednesday morning:

  • AMAG Pharmaceuticals (AMAG) Started as Overweight at JPMorgan
  • Andersons (ANDE) Started as Outperform at Oppenheimer
  • Bank of America (BAC) Raised to Market Perform at KBW
  • BMC Software (BMC) Raised to Neutral at JPMorgan
  • Cadence Design Systems (CDNS) Raised to Overweight at JPMorgan
  • Citrix Systems (CTXS) Raised to Overweight at JPMorgan
  • Inter Parfums (IPAR) Raised to Buy at Piper Jaffray
  • Jefferies (JEF) Raised to Market Perform at KBW
  • McDermott International (MDR) Started as Buy at American Tech Research
  • Myriad Genetics (MYGN) Started as Outperform at Oppenheimer
  • NuVasive (NUVA) Started as Overweight as JPMorgan
  • Symantec (SYMC) Raised to Overweight at JPMorgan

Jon C. Ogg
October 8, 2008

Top Pre-Market Analyst Upgrades (CTRP, GS, LEH, MRVL, NLC, NUVA, PRU, RF, RIG, USG, ZION)

These are some of the top early bird analyst upgrades and positive calls we are seeing this Monday morning with more than two hours to the open:

  • Ctrip.com (CTRP) Started as Outperform at Credit Suisse.
  • Goldman Sachs (GS) Raised to Buy at Merrill Lynch.
  • Lehman Brothers (LEH) Raised to Neutral at Merrill Lynch.
  • Marvell Tech (MRVL) Raised to Outperform at Morgan Keegan.
  • Nalco Holding (NLC) Raised to Neutral (from Sell) at Goldman Sachs.
  • NuVasive (NUVA) Started as Buy at Piper Jaffray.
  • Prudential Financial (PRU) Raised to Outperform at FBR.
  • Regions Financial (RF) Raised To Market Perform at FBR.
  • Transocean (RIG) Raised to Hold from Sell at Deutsche Bank.
  • USG (USG) Raised to Neutral at JPMorgan.
  • Zions Bancorp (ZION) Raised to Outperform at FBR.

Jon C. Ogg
September 8, 2008

Looking for the Next Intuitive Surgical After The Barron’s Pan (ISRG, HNSN, NUVA)

Intuitive_surgical_logoThis weekend and this last week has created a lot of buzz around the mighty medical robotics player Intuitive Surgical Inc. (NASDAQ: ISRG).  For starters, it did beat earnings and it raised 2008 guidance.  But this weekend there is an article as the cover story of Barron’s questioning its long-term valuations.  While the article isn’t 100% of a total panning of the company, it does show some discrepancies over what the company believes is the total market opportunity versus what some independents believe.

It seems that Intuitive has its believers and its critics, and to prove it the most recent short data (about to be old) showed that almost 4.1 million shares (over 10% of the float) is listed as being in the short interest.  This is what happens after stocks keep an interest and fascination after a rise of 20-times or more in the stock price in less than a decade.

We wanted to discuss two other stocks that are related to this stock to see if there are still opportunities out there in the sector.  The two we are reviewing here are Hansen Medical Inc. (NASDAQ: HNSN) and NuVasive Inc. (NASDAQ: NUVA).

Read More »